These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 13671786)

  • 21. Effect of amphotericin B on the metabolic profiles of Candida albicans.
    Cao Y; Zhu Z; Chen X; Yao X; Zhao L; Wang H; Yan L; Wu H; Chai Y; Jiang Y
    J Proteome Res; 2013 Jun; 12(6):2921-32. PubMed ID: 23672250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
    De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
    J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative in vitro antifungal susceptibility activity of amphotericin B versus amphotericin B methyl ester against Candida albicans ocular isolates.
    Thanathanee O; Miller D; Ringel DM; Schaffner CP; Alfonso EC; O'Brien TP
    J Ocul Pharmacol Ther; 2012 Dec; 28(6):589-92. PubMed ID: 22788845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disruption of mitochondrial function in Candida albicans leads to reduced cellular ergosterol levels and elevated growth in the presence of amphotericin B.
    Geraghty P; Kavanagh K
    Arch Microbiol; 2003 Apr; 179(4):295-300. PubMed ID: 12640519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acetylenic acids inhibiting azole-resistant Candida albicans from Pentagonia gigantifolia.
    Li XC; Jacob MR; ElSohly HN; Nagle DG; Smillie TJ; Walker LA; Clark AM
    J Nat Prod; 2003 Aug; 66(8):1132-5. PubMed ID: 12932143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Dormancy of Candida albicans ATCC10231 in the presence of amphotericin B. Investigation using the scanning electron microscope (SEM)].
    Benmansour W; Boucherit-Otmani Z; Boucherit K
    J Mycol Med; 2014 Sep; 24(3):e93-100. PubMed ID: 24768064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparative study of the post-antifungal effect (PAFE) of amphotericin B, triazoles and echinocandins on Aspergillus fumigatus and Candida albicans.
    Manavathu EK; Ramesh MS; Baskaran I; Ganesan LT; Chandrasekar PH
    J Antimicrob Chemother; 2004 Feb; 53(2):386-9. PubMed ID: 14729762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Betamethasone augments the antifungal effect of menadione--towards a novel anti-Candida albicans combination therapy.
    Jakab Á; Emri T; Sipos L; Kiss Á; Kovács R; Dombrádi V; Kemény-Beke Á; Balla J; Majoros L; Pócsi I
    J Basic Microbiol; 2015 Aug; 55(8):973-81. PubMed ID: 25707543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro interactions of approved and experimental drugs against Candida drugs against Candida spp.
    Repp KK; Hogan F; Pettit GR; Pettit RK
    J Chemother; 2008 Feb; 20(1):137-9. PubMed ID: 18343758
    [No Abstract]   [Full Text] [Related]  

  • 30. Antifungal activity of Coriandrum sativum essential oil, its mode of action against Candida species and potential synergism with amphotericin B.
    Silva F; Ferreira S; Duarte A; Mendonça DI; Domingues FC
    Phytomedicine; 2011 Dec; 19(1):42-7. PubMed ID: 21788125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluconazole and amphotericin-B resistance are associated with increased catalase and superoxide dismutase activity in Candida albicans and Candida dubliniensis.
    Linares CE; Giacomelli SR; Altenhofen D; Alves SH; Morsch VM; Schetinger MR
    Rev Soc Bras Med Trop; 2013; 46(6):752-8. PubMed ID: 24474018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antifungal activity against Candida albicans of starch Pickering emulsion with thymol or amphotericin B in suspension and calcium alginate films.
    Cossu A; Wang MS; Chaudhari A; Nitin N
    Int J Pharm; 2015 Sep; 493(1-2):233-42. PubMed ID: 26231107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparisons of the susceptibilities of planktonic and adherent Candida albicans to antifungal agents: a modified XTT tetrazolium assay using synchronised C. albicans cells.
    Hawser S
    J Med Vet Mycol; 1996; 34(2):149-52. PubMed ID: 8732362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The effect of amphotericin B on the oxygen consumption of Candida albicans].
    DROUHET E; HIRTH L; LEBEURIER G
    C R Hebd Seances Acad Sci; 1958 Dec; 247(25):2416-9. PubMed ID: 13619122
    [No Abstract]   [Full Text] [Related]  

  • 35. Combined effects of hyperbaric oxygen and antifungal agents on the growth of Candida albicans.
    Gudewicz TM; Mader JT; Davis CP
    Aviat Space Environ Med; 1987 Jul; 58(7):673-8. PubMed ID: 3304267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of imidazole- and triazole-derivative antifungal compounds on the growth and morphological development of Candida albicans hyphae.
    Odds FC; Cockayne A; Hayward J; Abbott AB
    J Gen Microbiol; 1985 Oct; 131(10):2581-9. PubMed ID: 2999296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of triacetin and nystatin with respect to their stability and effect on Candida albicans.
    KUBISTA RA; DERSE PH
    Antibiot Chemother (Northfield); 1959 Sep; 9():546-9. PubMed ID: 14412413
    [No Abstract]   [Full Text] [Related]  

  • 38. Characterization of the inhibitory effect of voriconazole on the fungicidal activity of amphotericin B against Candida albicans in an in vitro kinetic model.
    Lignell A; Löwdin E; Cars O; Sjölin J
    J Antimicrob Chemother; 2008 Jul; 62(1):142-8. PubMed ID: 18408237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The effects of some antimycotic substances on Candida albicans].
    BRUN R; MOZER JJ; JADASSOHN W
    Schweiz Med Wochenschr; 1953 Feb; 83(6):135-6. PubMed ID: 13075995
    [No Abstract]   [Full Text] [Related]  

  • 40. An evaluation of amphotericin B in vitro and in vivo in mice against Coccidioides immitis and Candida albicans, and preliminary observations concerning the administration of amphotericin B to man.
    HALDE C; NEWCOMER VD; WRIGHT ET; STERNBERG TH
    J Invest Dermatol; 1957 Mar; 28(3):217-31; discussion, 231-2. PubMed ID: 13429161
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.